GO:0018958 phenol-containing compound metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0018958 describes the chemical reactions and pathways involving a phenol, any compound with one or more hydroxyl groups directly attached to an aromatic carbon ring.
• Phenol-containing compounds are central to drug discovery, where the phenol moiety is both a pharmacophore and a metabolic liability that medicinal chemists now seek to embrace rather than replace.
• Microbial communities can degrade phenol in wastewater through metabolic division of labor, a process relevant to environmental bioremediation.
• Phenol-containing biomolecules and drugs can be selectively functionalized by late-stage C-H amination and alkylamination, enabling new chemical probes and therapeutics.
• Phenol binds to R6 insulin hexamers and stabilizes their conformation, illustrating how phenol-containing compounds can modulate protein structure and function.
• Dysregulation of phenol metabolism is linked to osteoarthritis and cancer, where tetrahydroquinoline derivatives induce ROS-mediated apoptosis in glioblastoma cells.
Description
Phenol-containing compound metabolic process (GO:0018958) is a biological process ontology term that encompasses the chemical reactions and pathways involving a phenol, defined as any compound containing one or more hydroxyl groups directly attached to an aromatic carbon ring. This term captures a wide range of biochemical transformations, from the microbial degradation of environmental phenols to the metabolic processing of phenolic drugs and endogenous phenolic metabolites in human cells. The importance of this process extends across medicinal chemistry, environmental science, and human health, as phenolic compounds are ubiquitous in nature and are frequently encountered as pharmaceuticals, pollutants, and signaling molecules. Researchers study GO:0018958 to understand how organisms detoxify, utilize, or modify phenolic substrates, and to exploit these pathways for drug development, bioremediation, and disease treatment. The phenol moiety is increasingly recognized not as a liability to be replaced but as a functional group to be embraced in drug design, owing to its ability to form hydrogen bonds and participate in diverse metabolic reactions. In environmental contexts, phenol-containing wastewater requires specialized microbial consortia for effective treatment, and the metabolic division of labor between co-cultured bacteria enhances phenol biodegradation. In human biology, phenol-containing compounds such as tyrosine derivatives and phenolic drugs undergo late-stage C-H functionalization, which can alter their pharmacological properties. Additionally, phenol binding to insulin hexamers modulates protein stability, highlighting the broader relevance of phenol-protein interactions. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0018958, its mechanisms, key genes, disease associations, and experimental models for CRISPR-based investigation.
phenol-containing compound metabolic process At A Glance
| GO ID | GO:0018958 |
|---|---|
| GO term | phenol-containing compound metabolic process |
| Ontology | biological_process |
| Synonym | carbolic acid metabolic process; carbolic acid metabolism; hydroxybenzene metabolic process; hydroxybenzene metabolism; phenol-containing compound metabolism |
| Definition | The chemical reactions and pathways involving a phenol, any compound containing one or more hydroxyl groups directly attached to an aromatic carbon ring. |
| Major function | Metabolism of phenolic compounds, including degradation, modification, and conjugation of phenols and their derivatives. |
| Related processes | Aromatic compound metabolism, xenobiotic biodegradation, drug metabolism, tyrosine metabolism. |
| Taxonomic range | Bacteria, archaea, eukaryotes, including humans. |
| Research relevance | Drug discovery, bioremediation, cancer therapy, metabolic engineering. |
What Is GO:0018958?
GO:0018958, phenol-containing compound metabolic process, is defined by QuickGO as the chemical reactions and pathways involving a phenol, any compound containing one or more hydroxyl groups directly attached to an aromatic carbon ring. This definition encompasses both the synthesis and breakdown of phenolic compounds, as well as their interconversion and conjugation. Synonyms for this term include carbolic acid metabolic process, carbolic acid metabolism, hydroxybenzene metabolic process, hydroxybenzene metabolism, and phenol-containing compound metabolism. The term is classified under the biological_process aspect of the Gene Ontology, indicating that it describes a series of molecular events rather than a physical entity or a single molecular function. Phenolic compounds are characterized by a hydroxyl group bonded directly to an aromatic ring, a structural feature that confers unique chemical reactivity, including susceptibility to oxidation, conjugation, and electrophilic substitution. This definition is intentionally broad to accommodate the diverse array of phenolic substrates and products across all domains of life, from bacterial phenol degradation to mammalian tyrosine metabolism.
Why Is phenol-containing compound metabolic process Important in Cell Biology?
GO:0018958 is critically important because phenolic compounds are ubiquitous in biology and industry, serving as pharmaceuticals, environmental pollutants, and endogenous metabolites. Understanding how organisms metabolize phenols enables the development of bioremediation strategies for phenol-containing wastewater, the design of drugs with improved metabolic stability, and the elucidation of disease mechanisms linked to phenolic metabolite dysregulation. The phenol moiety is present in numerous drugs, and its metabolic fate can determine efficacy and toxicity, making this process a key consideration in medicinal chemistry. Moreover, microbial phenol degradation pathways are model systems for studying metabolic division of labor and community-level interactions. In human health, phenolic compounds such as tyrosine derivatives are subject to late-stage functionalization, and their altered metabolism has been implicated in osteoarthritis and cancer. Thus, GO:0018958 bridges fundamental biochemistry, environmental microbiology, and translational medicine.
• Phenolic compounds are common environmental pollutants, and their microbial degradation is essential for wastewater treatment.
• The phenol moiety is a frequent pharmacophore in drugs, and its metabolism affects drug half-life and toxicity.
• Late-stage C-H amination of phenol-containing biomolecules enables rapid diversification of drug candidates.
• Phenol binding to insulin hexamers stabilizes the protein, illustrating its role in protein-ligand interactions.
• Dysregulated phenol metabolism is associated with osteoarthritis, where selenoprotein iodothyronine deiodinase expression is altered.
• Tetrahydroquinoline derivatives, which contain phenolic-like structures, induce ROS-mediated apoptosis in glioblastoma cells.
• Metabolic division of labor in bacterial co-cultures enhances phenol biodegradation, offering insights for synthetic ecology.
• Understanding phenol metabolism supports the development of green chemistry approaches for drug synthesis.
• Phenol-containing compounds can serve as probes for studying enzyme mechanisms and protein structure.
• CRISPR-based models of phenol metabolic genes can reveal causal roles in disease and enable target validation.
What Happens During phenol-containing compound metabolic process?
Uptake and Initial Activation of Phenolic Substrates
In simple terms: Cells first bring phenolic compounds inside and chemically activate them so they can be broken down or modified.
The first step in phenol-containing compound metabolic process is the recognition and uptake of phenolic substrates, which can occur through passive diffusion or specific transport proteins. Once inside the cell, phenols may undergo initial activation, such as hydroxylation or phosphorylation, to increase their reactivity. In microbial systems, phenol is often converted to catechol by phenol hydroxylase before ring cleavage. In mammalian cells, phenolic drugs and metabolites can be activated by phase I enzymes to expose reactive groups for subsequent conjugation. The diversity of phenolic substrates means that uptake and activation mechanisms vary widely, but the common theme is the generation of a more reactive intermediate that can enter downstream pathways.
Ring Cleavage and Degradation Pathways
In simple terms: The aromatic ring of the phenol is broken open so the carbon atoms can be used as energy or building blocks.
For many phenolic compounds, the central metabolic event is the cleavage of the aromatic ring. In bacteria, catechol is cleaved by either ortho- or meta-cleavage dioxygenases, leading to intermediates of the tricarboxylic acid cycle. This process is essential for the complete mineralization of phenol and its derivatives. In co-cultures, metabolic division of labor can occur, where one organism performs initial ring cleavage and another consumes the resulting metabolites, enhancing overall degradation efficiency. In eukaryotic systems, aromatic ring cleavage is less common for phenols, but oxidative dehalogenation and ring opening can occur in specialized pathways. The enzymes involved in ring cleavage are often dioxygenases that incorporate molecular oxygen into the substrate, a hallmark of aerobic phenol degradation.
Conjugation and Detoxification
In simple terms: Cells attach chemical groups to phenols to make them less toxic and easier to excrete.
In addition to degradation, phenol-containing compound metabolic process includes conjugation reactions that modify phenolic groups to alter their solubility and biological activity. Common conjugations include glucuronidation, sulfation, and methylation, which are catalyzed by transferases such as UDP-glucuronosyltransferases and sulfotransferases. These reactions typically inactivate phenolic drugs and facilitate their excretion. In plants and microbes, glycosylation of phenols serves similar detoxification and storage functions. The balance between degradation and conjugation determines the fate of a phenolic compound in an organism, and both routes are considered part of GO:0018958.
Late-Stage Functionalization of Phenol-Containing Biomolecules
In simple terms: Chemists and enzymes can add new chemical groups to phenols at the last step, creating diverse derivatives.
Recent advances in chemical biology have highlighted the ability to perform late-stage C-H functionalization of phenol-containing biomolecules, including tyrosine residues and phenolic drugs. This process, while often synthetic, mirrors natural enzymatic modifications and can be used to generate novel compounds with altered properties. For example, site-selective C-H amination of phenol-containing biomolecules enables the introduction of amine groups at specific positions on the aromatic ring. Similarly, radical C-H alkylamination of tyrosine compounds and phenol-containing drugs allows for the attachment of alkylamine chains. These transformations are relevant to GO:0018958 because they represent metabolic-like modifications of phenolic substrates, and the enzymes that catalyze similar reactions in vivo are part of the phenol metabolic network.
Phenol-Protein Interactions and Structural Modulation
In simple terms: Phenol molecules can bind to proteins and change their shape or stability.
Phenol-containing compounds can also participate in metabolic processes by binding to proteins and modulating their function. A classic example is the binding of phenol to R6 insulin hexamers, which stabilizes the hexameric form and influences insulin storage and release. This interaction is not a metabolic conversion per se, but it falls under the broad definition of phenol-containing compound metabolic process because it involves the biological handling of a phenol. Such binding events can affect protein stability, activity, and interactions, and they are relevant to drug design and toxicology. Understanding these non-covalent interactions is essential for a complete picture of how phenols affect biological systems.
Key Genes Involved in GO:0018958 phenol-containing compound metabolic process
The following genes and proteins are involved in various aspects of phenol-containing compound metabolic process, including degradation, conjugation, and functionalization, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Stenotrophomonas sp. N5 genes | Phenol degradation in co-culture | Model for metabolic division of labor in bioremediation |
| Advenella sp. B9 genes | Phenol degradation in co-culture | Enhances phenol biodegradation through synergistic interactions |
| Phenol hydroxylase | Converts phenol to catechol | Key enzyme in microbial phenol degradation |
| Catechol dioxygenase | Cleaves aromatic ring of catechol | Central to aerobic phenol mineralization |
| UDP-glucuronosyltransferases | Conjugates phenols with glucuronic acid | Drug metabolism and detoxification |
| Sulfotransferases | Conjugates phenols with sulfate | Phase II metabolism of phenolic drugs |
| Tyrosine | Phenol-containing amino acid | Substrate for late-stage C-H functionalization |
| Selenoprotein iodothyronine deiodinase | Selenoprotein with phenol-related activity | Expressed in osteoarthritis, linked to phenol metabolism |
| Tetrahydroquinoline derivatives | Induce ROS-mediated apoptosis | Potential anticancer agents in glioblastoma |
| Insulin | Binds phenol, forms R6 hexamer | Model for phenol-protein interactions |
| Phenol hydroxylase (mammalian) | Oxidizes phenolic drugs | Phase I metabolism |
| Cytochrome P450 enzymes | Oxidize phenolic compounds | Drug and xenobiotic metabolism |
| Glutathione S-transferases | Conjugate phenols with glutathione | Detoxification of reactive phenolic metabolites |
| Methyltransferases | Methylate phenolic hydroxyl groups | Inactivation of phenolic compounds |
| Glycosyltransferases | Glycosylate phenols | Detoxification and storage in plants and microbes |
| Peroxidases | Oxidize phenols using peroxide | Lignin degradation and phenol polymerization |
| Laccases | Oxidize phenols with oxygen | Bioremediation and green chemistry |
How Is phenol-containing compound metabolic process Regulated?
The regulation of phenol-containing compound metabolic process is multifaceted and depends on the organism and the specific phenolic substrate. In bacteria, phenol degradation genes are often controlled by transcriptional regulators that respond to the presence of phenol or its metabolites, ensuring that the degradative enzymes are expressed only when needed. In co-cultures, the division of labor is regulated by metabolite exchange and quorum sensing, which coordinate the activities of different species. In mammalian cells, the expression of phase I and phase II enzymes involved in phenol metabolism is regulated by nuclear receptors such as the aryl hydrocarbon receptor (AhR) and the constitutive androstane receptor (CAR), which sense xenobiotics and induce detoxification pathways. Additionally, post-translational modifications and feedback inhibition can modulate enzyme activity. For example, the binding of phenol to insulin hexamers is influenced by pH and metal ions, which regulate the stability of the complex. The regulation of late-stage functionalization reactions in chemical biology is achieved through catalyst design and reaction conditions, but in vivo, similar modifications may be regulated by enzyme specificity and substrate availability. Overall, the regulation of GO:0018958 ensures that phenolic compounds are metabolized efficiently while minimizing toxicity.
phenol-containing compound metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Selenoprotein iodothyronine deiodinase | Osteoarthritis | Knockout or overexpression in chondrocytes |
| Tetrahydroquinoline derivatives (target genes unknown) | Glioblastoma | Point mutations in ROS pathway genes |
| UDP-glucuronosyltransferases | Drug metabolism disorders | Knock-in of variant alleles |
| Phenol hydroxylase (microbial) | Bioremediation failure | Knockout in Stenotrophomonas sp. |
| Insulin | Diabetes and insulin storage | Knock-in of phenol-binding site mutations |
Phenol Metabolism in Osteoarthritis
Osteoarthritis is a degenerative joint disease characterized by cartilage breakdown and inflammation. Recent studies have implicated selenoprotein iodothyronine deiodinase, an enzyme involved in phenol-related metabolism, in osteoarthritis pathogenesis. The expression of this selenoprotein is altered in osteoarthritis, suggesting that dysregulated phenol metabolism may contribute to disease progression. Although the exact mechanisms remain unclear, the link between phenol metabolism and osteoarthritis highlights the importance of GO:0018958 in musculoskeletal health.
Phenolic Compounds and Glioblastoma
Glioblastoma is an aggressive brain cancer with limited treatment options. Tetrahydroquinoline derivatives, which contain phenolic-like structures, have been shown to induce ROS-mediated apoptosis in glioblastoma cells. This suggests that phenolic compounds and their metabolic processing can influence cancer cell survival. The generation of reactive oxygen species (ROS) by these derivatives may overwhelm the antioxidant capacity of cancer cells, leading to cell death. Understanding how phenol-containing compound metabolic process interacts with ROS signaling could inform the development of new glioblastoma therapies.
Phenol-Containing Drugs and Metabolic Liability
Many drugs contain phenol moieties, and their metabolism can lead to rapid clearance or toxic metabolites. The medicinal chemistry community has historically sought to replace phenol groups to improve drug properties, but recent trends emphasize embracing the phenol moiety for its beneficial interactions. Late-stage C-H functionalization of phenol-containing drugs allows for the generation of analogs with improved metabolic stability and potency. Dysregulation of phenol metabolism can therefore affect drug efficacy and safety, making GO:0018958 relevant to pharmacology and personalized medicine.
From phenol-containing compound metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate phenol degradation? | Knockout of gene X in bacterial co-culture |
| Does a point mutation in a phenol-metabolizing enzyme alter substrate specificity? | Point mutation knock-in in cell lines |
| Can overexpression of a phenol conjugation enzyme reduce drug toxicity? | Overexpression of UGT or SULT in hepatocytes |
| Does a tagged phenol hydroxylase localize to specific cellular compartments? | Tagged knock-in of phenol hydroxylase |
| Does a disease-associated variant affect phenol metabolism? | Knock-in of the variant allele in patient-derived cells |
| Can CRISPR library screening identify genes required for phenol tolerance? | Genome-wide knockout library in phenol-treated cells |
How to Study the phenol-containing compound metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Phenolic metabolites and intermediates | Profiling phenol degradation and conjugation |
| RNA-seq | Gene expression changes | Identifying genes regulated by phenols |
| Enzyme activity assay | Catalytic activity of phenol-metabolizing enzymes | Validating enzyme function |
| CRISPR knockout | Loss-of-function phenotypes | Testing gene essentiality for phenol metabolism |
| CRISPR knock-in | Gain-of-function or tagged alleles | Studying disease variants |
| CRISPR point mutation | Specific amino acid changes | Dissecting catalytic residues |
| CRISPR library screening | Genome-wide fitness in phenol | Identifying novel phenol resistance genes |
| Isothermal titration calorimetry | Binding affinity of phenol to proteins | Studying phenol-insulin interactions |
Metabolomics and Mass Spectrometry
Metabolomics approaches, particularly liquid chromatography-mass spectrometry (LC-MS), are essential for profiling phenolic compounds and their metabolites in biological samples. These methods can quantify phenol degradation intermediates, conjugation products, and late-stage functionalization adducts. Targeted metabolomics can measure specific phenolic drugs and their metabolites, while untargeted approaches can discover novel phenol-containing compounds. In microbial studies, metabolomics reveals the division of labor in co-cultures by tracking metabolite exchange.
Transcriptomics and RNA-seq
RNA sequencing (RNA-seq) is used to identify genes differentially expressed during phenol metabolism. In bacteria, transcriptomic analysis of phenol-degrading consortia can reveal which genes are upregulated in response to phenol. In mammalian cells, RNA-seq can uncover pathways affected by phenolic drug treatment or genetic perturbations. Combining RNA-seq with CRISPR screens can pinpoint regulatory networks controlling GO:0018958.
Enzyme Activity Assays
Enzyme activity assays are used to measure the catalytic activity of phenol-metabolizing enzymes, such as phenol hydroxylase, catechol dioxygenases, and transferases. These assays typically monitor substrate consumption or product formation using spectrophotometric or fluorometric methods. For example, phenol hydroxylase activity can be measured by the conversion of phenol to catechol, which can be detected by colorimetric assays. Such assays are critical for validating enzyme function and for screening inhibitors or activators.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 genome editing enables the creation of knockout, knock-in, and point-mutation models to study the function of genes involved in phenol-containing compound metabolic process. For instance, knocking out a putative phenol hydroxylase gene in a bacterial strain can confirm its role in phenol degradation. In human cells, knock-in of disease-associated variants can reveal their impact on phenol metabolism and drug response. CRISPR screens can systematically identify genes required for phenol tolerance or sensitivity.
How CRISPR Can Be Used to Study GO:0018958 phenol-containing compound metabolic process
Knockout
CRISPR knockout models are used to delete genes involved in phenol-containing compound metabolic process, such as phenol hydroxylases, catechol dioxygenases, and conjugation enzymes. In bacteria, knockout of a phenol degradation gene can abolish the ability to grow on phenol as a sole carbon source, confirming its essential role. In mammalian cells, knockout of a phase II enzyme can lead to accumulation of toxic phenolic metabolites, providing a model for drug-induced toxicity. Knockout studies are foundational for establishing causality between a gene and a phenol metabolic phenotype.
Point Mutation
CRISPR point mutation models introduce specific amino acid substitutions to dissect the catalytic mechanism of phenol-metabolizing enzymes. For example, mutating the active-site residues of phenol hydroxylase can reveal their roles in substrate binding and catalysis. Point mutations can also model human genetic variants associated with altered phenol metabolism, such as those in UDP-glucuronosyltransferases. These models are valuable for understanding enzyme structure-function relationships and for predicting drug metabolism.
Knock-in
CRISPR knock-in models allow the insertion of tagged or variant alleles at endogenous loci. Tagged knock-in of a phenol-metabolizing enzyme enables live-cell imaging and proteomic analysis of its localization and interactions. Knock-in of disease-associated variants, such as those in selenoprotein iodothyronine deiodinase, can model osteoarthritis-related phenotypes. Knock-in of reporter genes under the control of phenol-responsive promoters can be used to monitor pathway activity in real time.
Overexpression
CRISPR overexpression models, often achieved by knock-in of a strong promoter or by using CRISPR activation (CRISPRa), are used to increase the expression of genes involved in phenol metabolism. Overexpression of a phenol conjugation enzyme can enhance detoxification of phenolic drugs and protect cells from toxicity. In bacteria, overexpression of phenol degradation enzymes can accelerate bioremediation of phenol-containing wastewater. Overexpression models are also useful for producing phenolic compounds in metabolic engineering applications.
How EDITGENE Supports phenol-containing compound metabolic process Research
Researchers studying phenol-containing compound metabolic process-related genes often need to determine whether a candidate gene is causally involved in phenol metabolism, drug response, or disease. EDITGENE provides comprehensive CRISPR gene editing services to create precisely tailored cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for phenol-containing compound metabolic process research.
Frequently Asked Questions About phenol-containing compound metabolic process
What is GO:0018958?
GO:0018958 is the Gene Ontology term for phenol-containing compound metabolic process, defined as the chemical reactions and pathways involving a phenol, any compound containing one or more hydroxyl groups directly attached to an aromatic carbon ring.
What genes are involved in phenol-containing compound metabolic process?
Genes involved include phenol hydroxylase, catechol dioxygenases, UDP-glucuronosyltransferases, sulfotransferases, and selenoprotein iodothyronine deiodinase, among others.
How is phenol metabolized in bacteria?
Bacteria metabolize phenol by converting it to catechol via phenol hydroxylase, followed by ring cleavage by catechol dioxygenases, ultimately entering the TCA cycle.
What is the role of phenol metabolism in drug discovery?
Phenol metabolism affects drug stability and toxicity; medicinal chemists now embrace the phenol moiety for its beneficial interactions and use late-stage functionalization to optimize drug candidates.
Can CRISPR be used to study phenol metabolism?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models can be used to study the function of genes involved in phenol-containing compound metabolic process.
What diseases are linked to phenol metabolism?
Diseases linked to phenol metabolism include osteoarthritis, glioblastoma, and drug metabolism disorders.
How does phenol bind to insulin?
Phenol binds to R6 insulin hexamers and stabilizes the hexameric conformation, influencing insulin storage and release.
What is metabolic division of labor in phenol degradation?
Metabolic division of labor refers to the cooperation between different bacterial species in a co-culture, where each performs part of the phenol degradation pathway, enhancing overall efficiency.
What methods are used to study phenol-containing compound metabolic process?
Methods include LC-MS metabolomics, RNA-seq, enzyme activity assays, and CRISPR genome editing.
Why is phenol-containing compound metabolic process important for bioremediation?
Phenol is a common environmental pollutant, and understanding its microbial degradation is essential for developing effective wastewater treatment strategies.
Conclusion
GO:0018958, phenol-containing compound metabolic process, encompasses a diverse array of biochemical pathways that are fundamental to environmental bioremediation, drug metabolism, and human health. From microbial degradation of phenol in wastewater to the late-stage functionalization of phenolic drugs, this process is central to many applied and basic research areas. Dysregulation of phenol metabolism has been linked to osteoarthritis and cancer, underscoring its clinical relevance. Advances in CRISPR genome editing now enable precise interrogation of the genes and pathways involved, offering new opportunities for therapeutic development and metabolic engineering. As the medicinal chemistry community continues to embrace the phenol moiety, a deeper understanding of GO:0018958 will be essential for designing safer and more effective drugs. Future research integrating multi-omics, CRISPR screens, and structural biology will further illuminate the complexities of phenol metabolism and its impact on human disease.
References
- 1. Ouvry G. 2026. Phenols: From Replacing to Embracing.. ChemMedChem 21(15):e70408 PMID: 42613858
- 2. Wang W et al.. 2019. Performance and recovery of a completely separated partial nitritation and anammox process treating phenol-containing wastewater.. Environ Sci Pollut Res Int 26(33):33917-33926 PMID: 29982943
- 3. Girón-Elola C et al.. 2023. Site-Selective C-H Amination of Phenol-Containing Biomolecules.. Org Lett 25(23):4383-4387 PMID: 37284781
- 4. Andrade-Sampedro P et al.. 2024. Late-Stage Radical C-H Alkylamination of Tyrosine Compounds and Phenol-Containing Drugs.. Org Lett 26(41):8668-8673 PMID: 39361972
- 5. Ren XM et al.. 2022. Biological Functions of Selenoprotein Iodothyronine Deiodinase and its Expression in Osteoarthritis.. Chin Med Sci J 37(2):142-150 PMID: 35796338
- 6. Li CM et al.. 2020. Enhancement of phenol biodegradation: Metabolic division of labor in co-culture of Stenotrophomonas sp. N5 and Advenella sp. B9.. J Hazard Mater 400:123214 PMID: 32585516
- 7. Koochakkhani S et al.. 2024. Novel tetrahydroquinoline derivatives induce ROS-mediated apoptosis in glioblastoma cells.. Eur J Pharm Sci 200:106842 PMID: 38936514
- 8. Berchtold H et al.. 1999. Binding of phenol to R6 insulin hexamers.. Biopolymers 51(2):165-72 PMID: 10397800
